<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03208595</url>
  </required_header>
  <id_info>
    <org_study_id>0201-17</org_study_id>
    <nct_id>NCT03208595</nct_id>
  </id_info>
  <brief_title>Endometrial Flora in Women Undergoing IVF Treatments</brief_title>
  <official_title>Endometrial Flora Sampling in Women Undergoing IVF/PGD Treatments</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tel-Aviv Sourasky Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tel-Aviv Sourasky Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Characterization of the female genital tract microbiome in women undergoing IVF treatment
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary goal With The purpose of our study is to examine the uterine microbiome by
      Next-generation sequencing of the bacteria specific regions .

      Vaginal and uterine swabs will be taken in different women undergoing IVF /PGD. Novel
      bacteria and results of taxonomy assignments will be examine to find correlation of uterine
      flora with IVF and obstetrical outcomes.

      The metagenomics approach will be used to seek previously unidentified bacterial species in
      the human upper genital tract.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 1, 2017</start_date>
  <completion_date type="Anticipated">August 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To assess endometrial caracteristicas in fertile and infertile women using next generation sequencing of bacterial identification</measure>
    <time_frame>2017-2020</time_frame>
    <description>Type of flora identified by next generation sequencing of bacterial identification</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To identify specific endometrial flora in association to faliure of IVF treatment</measure>
    <time_frame>2017-2020</time_frame>
    <description>Type of flora identified by NGS</description>
  </primary_outcome>
  <primary_outcome>
    <measure>to assess the feasibility of endometrial sampling in women undergoing embryo transfer by a standart transfer cateteher</measure>
    <time_frame>2017-2020</time_frame>
    <description>Mode of endometrial sampling</description>
  </primary_outcome>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Endometrial Flora Characterization in Infertile Women</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Endometrial sampling of a Typical Embryo transfer catheter</intervention_name>
    <description>no intervention no additional change from unit protocol</description>
    <other_name>no intervention</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Bacterial DNA only
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        patients undergoing transfer of a single euploid blastocyst .The specimen will be obtaine
        from the embryo transfer catheter.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All undergoning IVF treatment

          -  Embryo transfer of one Blastocyst

        Exclusion Criteria:

          -  More then one Embryo Transfer

          -  Recent antibacterial treatment
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>All infertile women</gender_description>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
  </eligibility>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 26, 2017</study_first_submitted>
  <study_first_submitted_qc>July 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 5, 2017</study_first_posted>
  <last_update_submitted>July 3, 2017</last_update_submitted>
  <last_update_submitted_qc>July 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tel-Aviv Sourasky Medical Center</investigator_affiliation>
    <investigator_full_name>michal roll</investigator_full_name>
    <investigator_title>Deputy Director General for R&amp;D</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

